Abstract:Background. Disorders in the production of neuroendocrine peptides in the digestive tract can cause changes in, intestinal motility and the formation of visceral hypersensitivity, characteristic of patients with irritable bowel syndrome (IBS). From this standpoint, of particular interest is the study of the role of a number of major endocrine cells (EC) of the colon, secreting motilin, vasoactive intestinal polypeptide, and somatostatin, in IBS. Aims to evaluate the density of ECs with different hormonal activities that secrete motilin, vasoactive intestinal polypeptide and somatostatin in the mucosa of the sigmoid colon in patients with IBS that occurs with constipation and diarrhea. Materials and methods. 85 patients with IBS were examined. The first group included 44 patients with diarrhea (IBSd), the second group included 41 patients with constipation (IBSc). The comparison group consisted of 36 practically healthy people. The diagnosis of IBS was based on the Rome IV criteria. Patients and healthy people were examined according to a single program, including clinical, instrumental (colonoscopy, ultrasound examination of the abdominal organs), laboratory (clinical blood test, feces for calprotectin and antibodies to gliadin in the presence of diarrhea), morphological and immunohistochemical methods. Results. The clinical picture of IBS corresponded to the classical manifestations of this pathology. Among patients with IBSc, there was a more frequent feeling of incomplete emptying of the intestine after defecation, compared with patients with IBSd (p 0.05). Among patients with IBSd, there was a statistically significant increase in the number of ECs producing motilin and vasoactive intestinal polypeptide, as well as a lower density of ECs secreting somatostatin, compared with the control group (p 0.05). In the IBSc group, there was a decrease in the number of ECs producing motilin, vasoactive intestinal polypeptide and an increase in the number of ECs producing somatostatin, compared with the control group (p 0.05). Conclusions. An increase in the number of cells producing motilin, vasoactive intestinal polypeptide and a decrease in the number of cells observed for the production of somatostatin in the mucosa of the sigmoid colon is characteristic of the manifestation of IBSd. At the same time, an increase in ECs secreting motilin, vasoactive intestinal polypeptide and an increase in cellular elements producing somatostatin reveals manifestations of IBSс.

The Role of Brain-Derived Neurotrophic Factor in Irritable Bowel Syndrome

Brain-derived Neurotrophic Factor Contributes to Abdominal Pain in Irritable Bowel Syndrome

Role of Brain-Derived Neurotrophic Factor in Endometriosis Pain

Increased Production of BDNF in Colonic Epithelial Cells Induced by Fecal Supernatants from Diarrheic IBS Patients

BDNF contributes to IBS-like colonic hypersensitivity via activating the enteroglia-nerve unit

Involvement Of Corticotropon-Relesing Factor And Receptors In Immune Cells In Irritable Bowel Syndrome

BDNF Modulates Intestinal Barrier Integrity Through Regulating the Expression of Tight Junction Proteins.

Pain Severity Correlates With Biopsy-Mediated Colonic Afferent Activation But Not Psychological Scores in Patients With IBS-D

The Role of Brain-Derived Neurotrophic Factor in Experimental Inflammation of Mouse Gut.

The neurobiology of irritable bowel syndrome

Pilot Study of Small Bowel Mucosal Gene Expression in Patients with Irritable Bowel Syndrome with Diarrhea.

BDNF/TRKB SNPs In Individuals With IBS; Associations With Pain And Psychological Symptoms In U.S. And UKBB Cohorts

Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study

NR 2 B-containing NMDA receptors contribute to diarrhea-predominant irritable bowel syndrome

Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study

Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain

[Brain-gut interactions in irritable bowel syndrome: physiological and psychological aspect]

Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome

NR2B-containing NMDA receptors contribute to diarrhea-predominant irritable bowel syndrome

The Role of Endocrine Cells of the Colon, Secreting Vasoactive Intestinal Polypeptide, Somatostatin and Motilin, in Irritable Bowel Syndrome, Occurring with Diarrhea and Constipation

Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome